The Weekly Roundup: July 18-22

ICYMI, this week we had stories about skin cancer, FDA approvals, vitiligo, consumer trends, and more.

What's New on Dermatology Times: July 18-22

Click to see a preview of what to expect this week.

Overview of Skin Damage by the Sun

Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.

Skin Damage in Light-Skinned Individuals Compared With Individuals With Skin of Color

Susan Taylor, MD, FAAD, compares how skin damage can occur in individuals with skin of color compared with individuals with light skin.

Optimizing Outcomes for Pediatric Infusion Therapy

An expert offers considerations and developmentally appropriate interventions to promote high-quality, patient-centered pediatric infusion care.

POLL: Women are More Likely to Develop Hidradenitis Suppurativa - True or False?

Click here to answer this week's poll.

Severe Hemorrhage from Infantile Hemangioma

A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.

The Mainstream Patient: July 18

This week's edition of the Mainstream Patient features stories about night creams, skincare routines, beauty sales, and more.

FDA Approves Ruxolitinib Cream 1.5% to Treat Nonsegmental Vitiligo

Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

Pointers with Dr Portela: Hormonal Acne

In this week’s Pointers with Dr Portela, the 208SkinDoc talks about how to overcome hormonal acne and other skin care tips.

Overview of Atopic Dermatitis in Patients of Skin of Color

Drs. Neal Bhatia and Angela Lamb provide an overview of atopic dermatitis and its prevalence in patients with skin of color (SOC).

Increasing Awareness of Advances in AD Management with Physicians and Patients

Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.

Phase I/II Study of Topical Biologic Shows Positive Results for the Treatment of Basal Cell Carcinoma

MW005 treatment for low-risk basal cell carcinoma would offer patients an alternative to surgical excision.

How Physicians Can Provide Better Care for Patients with Chronic Conditions

Technology and care navigators are key to managing this growing population

Stephen Stripling, MD, FAAP, Discusses Study of Berdazimer Gel for Molluscum Contagiosum

Results published in the Journal of the American Medical Association (JAMA) Dermatology detailed the efficacy and safety of berdazimer gel 10.3%, in the treatment of molluscum contagiosum.

How Ruxolitinib Will Change the Future of Vitiligo Treatment

Pearl Grimes, MD, FAAD, and director of the Grimes Center of Medical and Aesthetic Dermatology and the Vitiligo & Pigmentation Institute of Southern California in Los Angeles, explains why the FDA approval of ruxolitinib cream 1.5% is monumental in the treatment of vitiligo.

Paper Reviews Studies Highlighting Multidisciplinary Approaches and Precision Medicine in AD

Studies show that patients with atopic dermatitis may benefit from a multidisciplinary approach.

Anti-Aging Skin Care Tips from AAD

The American Academy of Dermatology Association shares its recommendations for anti-aging products and reducing skin aging.